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Aims: Type 2 diabetes has been linked to fatigue, but results on type 1 diabetes are ambiguous. Our aim
was to determine if type 1 diabetes is associated with fatigue and whether the fatigue is due to com-
plications or to the disease itself.
Methods: The Multidimensional Fatigue Inventory (MFI-20), was submitted to all 435 adult patients with
type 1 diabetes in the National Diabetes Register at the Sunderby Hospital clinic and to a control group of
2500 persons. The participation rate was 62% in both groups.
Results: Type 1 diabetes was associated with greater fatigue, with a 1.4-point difference (0.9e1.9, 95% CI)
in general fatigue on a scale of 4e20. Type 1 diabetes was an independent predictor of fatigue, as were
cardiovascular and cerebrovascular disease. Women with long diabetes duration but without compli-
cations experienced more fatigue than women in the general population (difference in general
fatigue ¼ 2.5, p ¼ 0.021), whereas men showed no signiﬁcant difference.
Conclusions: Type 1 diabetes is associated with greater fatigue, partly ascribed to vascular disease. Type 1
diabetes of long duration might be associated with fatigue regardless of classical complications, but
further research is needed to conﬁrm results.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Type 1 diabetes is a chronic condition prevalent in about 30 000
people in Sweden [1]. The consequences of the condition vary
among patients e common complications include nephropathy,
diabetic foot disease, retinopathy, ischemic heart disease (IHD), and
stroke. Possible effects upon quality of life, cognition and vitality are
little studied.
Fatigue is deﬁned by Medical Subject Headings (MeSH) as “[t]he
state of weariness following a period of exertion, mental or phys-
ical, characterized by a decreased capacity for work and reduced
efﬁciency to respond to stimuli.” However, fatigue can be deﬁned in
many ways [2], and the deﬁnition above seems applicable primarily
to healthy individuals. Amongst individuals with a disease, fatigue
might be experienced as tiredness at rest, lack of endurance or loss
of vigor [3]. Associations have been found between fatigue and
several chronic conditions, including multiple sclerosis (MS) [4],
chronic obstructive pulmonary disease (COPD) [5], systemic lupusSunderby Hospital, 971 80
2834 02.
Inc. This is an open access article uerythematosus (SLE) [6], rheumatoid arthritis (RA) [7], and cancer
[8]. Type 2 diabetes and themetabolic syndrome are also associated
with fatigue [9]. Fatigue could be the consequence of disturbances
in cognition.
Both type 1 and type 2 diabetes have been linked to cognitive
decrements [10]. Studies on fatigue amongst type 1 diabetic
patients are scarce and ambiguous: Pediatric type 1 diabetic
patients showed more fatigue than their healthy peers in a 2009
study [11]. Amongst adults, one small study indicated that type
1 diabetes is not associated with increased fatigue [12]. How-
ever, a larger study from 2013 found a signiﬁcant association
between type 1 diabetes and fatigue [13]. Patients even reported
fatigue as the most troublesome diabetes-related symptom. The
prevalence of fatigue amongst patients with type 1 diabetes is
most likely inﬂuenced by both lifestyle and the psychological
stress related to the burden of living with a chronic condition
[14]. Stroke and IHD, two possible complications of type 1 dia-
betes, have been linked to fatigue [15e17].
Our main aim was to determine if fatigue is more common
amongst patients with type 1 diabetes than in the general popu-
lation. A secondary aim was to determine whether a possible
difference in fatigue might be related to complications or type 1
diabetes itself.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Number of participants and participation percentage in the patients and control
group according to age
Age MONICA Patients MONICA Patients
n Participation rate
18e34 239 60 48% 41%
35e44 290 52 58% 66%
45e54 340 59 68% 74%
55e64 362 44 72% 70%
65e81 326 51 65% 80%
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Design
In a cross-sectional study, a questionnaire was distributed to all
patients over 18 years of age with type 1 diabetes registered in the
Swedish National Diabetes Register (NDR) at the Section of Endo-
crinology, Department of Medicine, Sunderby Hospital e a sample
of convenience consisting of 435 persons. That clinic follows all
patients with type 1 diabetes, classiﬁcation was determined by the
treating clinician, in the cities of Luleå and Boden, with an
approximate catchment area of 100 000. The patients receiving the
questionnaire comprised an estimated 90% of all patients with type
1 diabetes in the area.
Data were collected from August 2012 to August 2014. The
questionnaire was sent out by mail, and by the end of the speciﬁed
time frame, non-responders still living in the county were con-
tacted by telephone and asked about their intention to participate
in the study. Between May and August 2014, the questionnaire was
also available at doctors’ and nurses’ appointments. Information
about diabetes duration and complications was retrieved from
patients’ medical records. The registered complications included
nephropathy (microalbuminuria, macroalbuminuria, end-stage
renal disease e ESRD), IHD, stroke (amongst the patients also
including transient ischemic attack e TIA), retinopathy (deﬁned as
laser treated retinopathy), diabetic foot disease (including neu-
ropathy with or without pain) and amputation.
The reference group consisted of participants in the 2014
Northern Sweden MONICA population survey, which primarily
investigated cardiovascular disease in relation to public health and
socioeconomic factors. The study was carried out in a manner
similar to the previous six surveys, which started in 1986 [18]. Each
survey included 2500 people between 25 and 74 years of age in the
counties of Norrbotten and Västerbotten, and that included the
cities of Luleå and Boden. Since MONICA is a population survey,
some people with diabetes were included in the reference group.
We did not exclude these.
In addition to comparing the groups above, patients with none
of the aforementioned complications but with 30 years or more of
diabetes duration were also analyzed separately from other dia-
betes patients. The cut-off age was chosen according to ongoing the
PROLONG study at Lund University, investigating mechanisms
protecting against diabetes complications.Table 2
Characteristics of participants, means (SD) or percentages. Patients with type 1
diabetes and the control group from the MONICA study
Characteristics MONICA
n ¼ 1557
Patients
n ¼ 268
Age (years) 50.8 (13.8) 48.0 (16.1)
Women 51.6% 46.6%Instruments
The questionnaires contained the Multidimensional Fatigue In-
ventory (MFI-20) and background questions concerning sex, age
and smoking habits. The reference group was also asked about
previous or current cardio- and cerebrovascular disease. The MFI-
20 consists of 20 questions and measures fatigue on ﬁve sub-
scales: general fatigue, physical fatigue, reduced activity, reduced
motivation and mental fatigue [19]. Each subscale ranges from 4 to
20, with higher scores indicating more fatigue. The Swedish
translation of MFI-20 has been previously accepted for scientiﬁc
purposes [20].Daily smokers 7.8% 6.0%
IHD 4.6% 9.0%
Stroke 2.4% 3.7%
Foot disease N/A 18.9%
Amputation N/A 1.1%
Nephropathy N/A 16.1%
Laser treated retinopathy N/A 25.2%
Diabetes duration (years) N/A 26.4 (15.0)
Age of onset (years) N/A 21.6 (14.3)Statistical analyses
To investigate any difference in fatigue between the patients and
the control group, MFI-20 scores were compared using indepen-
dent samples t-test. Differences between groups are denoted by D.
When comparing small groups, theManneWhitneyU test was used
(stated in the results).Using data from all patients and controls, linear regression was
performed with general fatigue as dependent variable and type 1
diabetes, IHD, stroke, age, sex and daily smoking as independent
variables. Factors previously linked to fatigue or with large differ-
ences between the groups were included in a linear regression
model including the control group and patients with 30 years or
more of diabetes duration but without major complications.
Investigated independent factors were sex, age, smoking, IHD,
stroke and type 1 diabetes.
Statistical analyses were performed with IBM SPSS Statistics
(version 22). All conﬁdence intervals (CI) are 95%. Given regression
model coefﬁcients are unstandardized. If any participant failed to
answer a question, which resulted in a missing value, the partici-
pant was excluded from that particular analysis, but included in
other analyses that did not require the variable in question. For
none of the fatigue dimensions was the rate of missing values
higher than 2.4 percent.
This study was approved by the Regional Ethics Review Board at
Umeå University, Sweden. All participants were provided with in-
formation in writing and consented to taking part in the study.Results
A total of 268 patients with type 1 diabetes and 1557 subjects
from the control group (MONICA) participated in the study,
resulting in a participation rate of 62% in each group (Table 1).
Participation frequencies varied with age: the lowest rate was
found amongst the youngest patients, whereas the oldest patients
were more prone to participate. The participation rate did not differ
between patients and controls according to gender (60% among
men and 63.5% among women). The mean age was about the same
in both groups, while the percentage of womenwas lower amongst
the patients. The frequencies of IHD and stroke were also higher
amongst the patients (Table 2).
Fatigue scores in all dimensions were signiﬁcantly higher
amongst the patients than in the control group (Table 3). When
Table 3
Fatigue scores for the patients with type 1 diabetes and for the control group from
the MONICA study
Means General
fatigue
Physical
fatigue
Reduced
activity
Reduced
motivation
Mental
fatigue
Men
MONICA
n ¼ 753
9.7 9.0 9.0 7.4 8.4
Patients
n ¼ 143
11.0 9.6 9.6 8.0 9.4
D 1.3 0.6 0.7 0.7 1.0
95% CI 0.6; 1.9 0.1; 1.3 0; 1.3 0.1; 1.2 0.4; 1.7
p <0.001 0.1 0.044 0.013 0.001
Women
MONICA
n ¼ 804
10.8 9.7 9.3 7.6 8.7
Patients
n ¼ 125
12.5 10.9 9.9 8.2 9.1
D 1.7 1.2 0.6 0.6 0.4
95% CI 0.9; 2.5 0.4; 2 0.2; 1.4 0; 1.2 0.3; 1.1
p <0.001 0.005 0.1 0.039 0.2
Both sexes
MONICA
n ¼ 1557
10.3 9.4 9.1 7.5 8.5
Patients
n ¼ 268
11.7 10.2 9.8 8.1 9.3
D 1.4 0.8 0.6 0.6 0.7
95% CI 0.9; 1.9 0.3; 1.4 0.1; 1.1 0.2; 1 0.3; 1.2
p <0.001 0.003 0.015 0.002 0.002
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general fatigue score was 1.4 on a scale of 4e20 (0.9e1.9, 95% CI).
Furthermore, fatigue scores, with the exception of mental fatigue,
were greater in women than in men in both the patient and the
control groups. In a linear regression model, type 1 diabetes, as well
as IHD and stroke, remained signiﬁcant predictors for higher scores
in all fatigue dimensions, after adjusting for age, sex and daily
smoking (p< 0.05). The association and the impact was strongest in
the general fatigue dimension (p < 0.001; B ¼ 1.18; R2 ¼ 10%).
Women with a diabetes duration of 30 years or more but
without major complications (micro- or macroalbuminuria, dia-
betic foot disease, IHD, stroke or laser treated retinopathy) showed
signiﬁcantly higher general fatigue scores than women in the gen-
eral population (n ¼ 16, D ¼ 2.5, p ¼ 0.021, comparison by Manne
Whitney U). However, there was no such difference seen in themen
(n ¼ 20, data not shown). When adjusting for IHD, stroke, sex, age
and daily smoking, having a diabetes duration of 30 years or more
but nomajor complications was signiﬁcantly associatedwith higher
general fatigue (p ¼ 0.047, B ¼ 1.26, R2 ¼ 10%). In a univariate
comparison between patients with and without the aforemen-
tioned complications, only stroke (D ¼ 3.0, p ¼ 0.067) and female
sex (D ¼ 1.5, p ¼ 0.014) were associated with greater general fatigue
scores (comparisons by ManneWhitney U).Discussion
This study indicates that there is an association between type 1
diabetes and fatigue. These ﬁndings contradict one previous, small
study [12] and support a recent, large Dutch study [13]. By and large
women had higher fatigue scores thanmen, which is to be expected
according to results in earlier studies [21,22]. The associations
found between IHD, stroke and fatigue were also consistent with
earlier ﬁndings [16,17]. However, it is interesting that type 1 dia-
betes was found to be an independent predictor of fatigue when
controlling for the age, sex, smoking, stroke and IHD.
While type 1 diabetes might be associated with fatigue
regardless of major complications, further research is needed toﬁnd out which patients are more likely to experience fatigue. One
such group identiﬁed in this study was women with 30 or more
years of diabetes duration but without major complications. While
the ﬁnding might be of clinical importance, the results should be
interpreted with caution due to a small group size (n¼ 16). The fact
that some patients seem protected from complications despite long
diabetes duration has been previously observed [23].
Some indications on mechanisms mediating the association
between type 1 diabetes per se and fatigue comes from studies of
patients with type 2 diabetes where an association with brain at-
rophy and cognitive impairment [24], and a link between high
blood glucose levels and dementia has been established [25]. In
type 2 diabetes patients who reported hypoglycemic symptoms, the
risk of excessive fatigue was almost doubled, compared with pa-
tients not reporting such symptoms [26]. A decrease in cognitive
performance and impaired sustained attention is associated with
type 1 diabetes [27,28]. Amongst patients with long-standing type 1
diabetes, cognitive dysfunction is associated with subcortical vol-
ume loss, regardless of microangiopathy [29].
Fluctuation in blood glucose levels, in the short and long term,
may thus be an important factor for impairment in higher mental
functions, possibly leading to fatigue. Research on the association
between recurrent, moderate hypoglycemia and cognitive impair-
ment amongst rats has given ambiguous results [30,31]. Severe
hypoglycemia is associated with worse cognitive functioning in
patients with type 1 diabetes [32]. However, the association be-
tween glucose levels, including variability, time in hyperglycemia,
HbA1c, and acute fatigue is reported as weak; instead, cognitive
behavioral factors are found to be related to chronic fatigue [13].
Results in the present study give no indications of possible mech-
anisms accounting for the difference in fatigue between patients
with type 1 diabetes and the general population. Although no as-
sociation was found between hypoglycemia and acute fatigue in
previous studies, a possible link between severe hypoglycemic
events in patients with type 1 diabetes and chronic fatigue cannot
be ruled out yet.
In our department all patients with type 1 diabetes are screened
for thyroid disease, deﬁciency of vitamin B12 or folic acid every two
years. We are also liberal with testing for Addison’s disease and
coeliac disease in patients with fatigue, weight loss or decreasing
insulin demand. Therefore we do not believe that undiagnosed
autoimmune disease explains our ﬁndings.
Are the higher fatigue scores found among patients with dia-
betes of such magnitude as to imply impact on quality of life? The
minimal clinically important difference (MCID) for MFI-20 has
been assessed in a radiotherapy population, ranging from 1.4 to 2.4
on the different subscales [33]. The differences between the con-
trol group and the diabetic patients found in this study were
below the MCID in all fatigue dimensions but no data on MCID in
patients with diabetes have been presented. Given previous pa-
tient reports on the burden of fatigue [13], this is somewhat un-
expected, but the concept of MCID is controversial and not easy to
deﬁne. However, for women with long standing diabetes without
complications, the difference in fatigue was found to be clinically
signiﬁcant.
It is unclear in what way the patients experience fatigue. The
MeSH deﬁnition, quoted in the introduction, does not seem to
capture the long-term weariness that might be associated with
chronic conditions. Fatigue takes many different forms, and many
deﬁnitions exist [2]. How do the patients describe their fatigue? Is it
a subjective feeling, or does it inﬂuence performance at work or on
daily activities? How is it affected bymental or physical activity and
rest? Is it connected to muscular strength or endurance? Although
the different scales of the MFI-20 try to grasp various aspects of
fatigue, further investigation on fatigue amongst patients with type
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research is needed to answer the questions above.
Further research is needed to ﬁnd the factors and mechanisms
that account for fatigue amongst diabetic patients without classical
complications and where the difference in fatigue cannot be
explained by IHD and stroke. Both psychological and physiological
factors are likely to contribute to fatigue symptoms, especially is the
concept of “diabetes burnout” [14] a target for further studies. Since
neuroimaging has shown associations between structural changes
and both type 1 and 2 DM, such examinations might prove helpful
to identify mechanisms for fatigue amongst diabetes patients [34].
Implications from the ﬁndings in this study suggest that clinicians
should be more alert to identify patients with type 1 diabetes who
have fatigue symptoms. For cancer patients, physical activity has
been shown to reduce fatigue [35], and cognitive behavior therapy
(CBT) has been proven efﬁcient in patients with chronic fatigue
syndrome [36]. Given that cognitive behavioral factors have been
associated with chronic fatigue [13] amongst patients with type 1
diabetes, perhaps CBT might help them as well. For selected pa-
tients, a thorough neuropsychological examination would possible
be helpful in order to individualize advice and support.
Strengths and limitations
The strengths of this study include using a database covering
almost all known patients with type 1 diabetes in the area, use of
established tools for measurement, and information about
diabetes duration and complications from patients’ medical
records. The Northern Sweden MONICA Study supplies a credible
population comparison and further increases the external validity
of the results. Unfavorable factors included limited geographic
coverage, low response rate amongst young people and self-
reported data on IHD and stroke in the control group. Data on
present or previous metabolic control and the incidence of hypo-
glycemia were not available but could have added important di-
mensions. All in all, the results obtained likely reﬂect the groups
sampled and might be applicable to other populations. Results
regarding nephropathy are not quite reliable, since most patients
with severe nephropathy and end-stage renal disease are treated
for their diabetes at the Section of Nephrology and were thus not
included in this study.
A trend toward increasing response rates with age was found in
both the patients and the control group. This pattern is familiar
from other studies [37]. However, a low response in certain age
groups might lead to problems with non-response bias. Indeed,
fatigue scores found in this study were compared to a general
German population [21], and young people in the present study
report higher fatigue scores than young people in the German
population. This suggests that our lower response rate in the lower
ages might be a sign of non-response bias amongst less fatigued
young people.
A large number of tests were performed, raising the issue of
mass signiﬁcance. No particular correction for multiple compari-
sons was made, mainly due to an ambition to keep the analysis as
simple as possible. Low p-values in most comparisons between
large groups indicate that results are signiﬁcant. However, the
number of patients with over 30 years of diabetes duration but
without complications was low. Therefore, ﬁndings on these pa-
tients should be interpreted with caution. The linear regression
models that investigated possible predictors for fatigue scores
showed low R2 values. This suggests that other factors than those
accounted for in this study might explain the associations between
type 1 diabetes and fatigue. Due to the nature of fatigue, this should
be expected. It should be underlined that the aim of this study was
not to set up a model of independent predictors, which couldexplain fatigue, but to ﬁnd a possible association between type 1
diabetes and fatigue, taking basic confounders into account. A
prospective study using repeated measures of fatigue along with
details on hypoglycaemia, HbA1c, physical activity, anthropometry
and socio-economy would in the future serve well to entangle
which factors that are most important in predicting fatigue among
patients with type 1-diabetes.
Conclusions
Type 1 diabetes is associated with fatigue. Part of the association
can be explained by macrovascular complications due to diabetes,
but even when taking vascular problems into account, the link re-
mains. Some of our ﬁndings might be of clinical importance.
Women with a long duration of diabetes without complications
experienced more fatigue than the control group, suggesting that
fatigue might be a complication of type 1 diabetes per se.
Future studies on the associations between type 1 diabetes and
fatigue should aim for higher participation rates and advanced
cognitive assessment. Fields of interest include the interaction be-
tween type 1 diabetes and its complications, sex and fatigue as well
as the possible links between biochemical markers and fatigue.
Neuroimaging could contribute to a better understanding of
mechanisms.
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